A comprehensive view of Sandoz International GmbH. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Sandoz invests US$49.9M into 20,182 square-foot, three-floor expansion at its antibiotics plant in Kundl, Austria; expansion to boost production of bulk formulation and fill-finish penicillins for global distribution

Teva Pharmaceutical names former Sandoz head Richard Francis as CEO effective January 1, 2023, to replace Kare Schultz who is retiring at the end of the year; Francis most recently served as CEO of Purespring Therapeutics and Forcefield Therapeutics

Sandoz invests US$49.9M to build three-floor, 20,182 square-foot building connected to penicillin production facility in Kundl, Austria; new plant to focus on bulk formulation, fill-finish for penicillin for global distribution

Teva Pharmaceuticals, Sandoz, Hikma Pharmaceuticals report amoxicillin is in short supply; FDA does not know when shortage will be resolved

Novartis spinning off Sandoz generics unit into a publicly traded standalone business, making it the largest generic drug company in Europe; in 2021 Sandoz had sales of US$9.6B, down 2% year-over-year due to 15% sales decline in US

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count